NKE
NIKE, Inc.
NKE has the edge over SON overall, supported by stronger valuation and stronger fundamentals.
SON
Sonoco Products Company
SON trails on the overall score without a compensating advantage in the available component scores.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
SON Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
SON's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
SON PE Valuation
SON has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
SON Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect SON's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over SON on earnings quality, reporting a profit while its opponent remains loss making.
SON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.61 | — |
| Q3 2026 | -$2.30 | -137% |
| Q2 2026 | $6.29 | +13% |
| Q1 2026 | $10.20 | +562% |
| Q4 2025 | $10.07 | +510% |
| Q3 2025 | $6.30 | +116% |
| Q2 2025 | $5.58 | +50% |
| Q1 2025 | $1.54 | -61% |
| Q4 2024 | $1.65 | -66% |
SON has swung to a loss: it lost $2.30 per share over the past year, after a profit the year before.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over SON on profitability, with a higher operating margin.
SON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | -4.2% |
| Q2 2026 | $1.9B | -1.3% |
| Q1 2026 | $1.7B | -1.9% |
| Q4 2025 | $1.8B | +30% |
| Q3 2025 | $2.1B | +27% |
| Q2 2025 | $1.9B | +18% |
| Q1 2025 | $1.7B | +4.4% |
| Q4 2024 | $1.4B | -17% |
SON has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -40 points |
| Q2 2026 | 10% | +1 points |
| Q1 2026 | 7.6% | +0.2 points |
| Q4 2025 | 29% | +33 points |
| Q3 2025 | 9.2% | +1.5 points |
| Q2 2025 | 9.2% | +0.5 points |
| Q1 2025 | 7.4% | +0.5 points |
| Q4 2024 | -4% | -12 points |
SON's operating margin was −31% last quarter, down 40 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
SON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.9M | -1.6% |
| Q2 2026 | $236.9M | +140% |
| Q1 2026 | -$430M | -$129.3M |
| Q4 2025 | $322.3M | +17% |
| Q3 2025 | $225.6M | +220% |
| Q2 2025 | $98.6M | +516% |
| Q1 2025 | -$300.8M | -477% |
| Q4 2024 | $274.3M | +74% |
SON has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
SON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -279K shares |
| 1 year | -0.1% | -146K shares |
| 3 years | +0.6% | +590K shares |
| 5 years | +0.1% | +77K shares |
| Available history | -1.7% | -1.7M shares |
SON has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $181,000 |
| Q2 2026 | $57,000 |
| Q1 2026 | $7M |
| Q4 2025 | $350,000 |
| Q3 2025 | $4,000 |
| Q2 2025 | $3,000 |
| Q1 2025 | $10.6M |
| Q4 2024 | $74,000 |
SON spent $8M buying back its own shares over the past year, down 29% from the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over SON on leverage, with a lower net debt burden relative to earnings.
SON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 5.3x | High |
| Q2 2025 | 6.2x | High |
| Q1 2025 | 9.3x | High |
| Q4 2024 | 9.4x | High |
SON's net debt is about 5.6 years of its operating earnings (EBITDA), up from 5.3 years a year ago.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
SON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 22.6 | Neutral |
SON's weekly RSI is 44 (neutral) and its Stochastic is 23 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
SON PE vs Consumer Cyclical Sector
| Metric | SON | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 18x | 56% below |
| PE % | 15 | 47 | 32 pts below |
SON has the edge over NKE on valuation relative to its sector.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
SON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $49.5 | 1.6% below |
| 20 week MA | $53.1 | 8.2% below |
| 50 week MA | $51.3 | 5% below |
| 100 week MA | $48.3 | 0.9% above |
| 200 week MA | $52.3 | 6.8% below |
SON's trend is mixed: it's above one of its five weekly moving averages, and 6.8% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
SON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.3 | $59.4 | -3.1% |
| 2021 | $59.4 | $55.5 | -6.6% |
| 2022 | $55.5 | $60.4 | +8.9% |
| 2023 | $60.4 | $55.9 | -7.5% |
| 2024 | $55.9 | $48.9 | -12% |
| 2025 | $48.9 | $43.5 | -11% |
| 2026 YTD | $43.5 | $48.7 | +12% |
SON has the edge over NKE on returns for 2026, with the stronger performance.